Indoor Biotechnologies

Indoor Biotechnologies is a long-established, privately-held player in the allergy and immunology space, operating primarily as a specialized service and product provider rather than a traditional therapeutic developer. Its core business model leverages deep scientific expertise to offer critical research tools (purified allergens), diagnostic kits for allergen detection, and contract research services (CRO) for preclinical studies. The company has a strong reputation, evidenced by collaborations with major government and academic bodies, and is positioned at the intersection of research, diagnostics, and environmental health.

Proprietary allergen purification expertise, MARIA® (Multiplex Array for Indoor Allergens) gold-standard testing platform, ELISA 2.0 kits, and ISO/IEC 17025:2017 accredited analytical services for allergen detection and quantification.

InBio competes in specialized segments against other providers of purified allergens (e.g., some academic centers), diagnostic kit manufacturers, and general CROs with immunology expertise. Its primary competitive advantage is its long-standing reputation, deep scientific authority, and the gold-standard status of its MARIA® platform for environmental allergen testing, creating a strong moat in its core markets.